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Introduction 
 
Stroke is a multi-factorial disease where combinations of risk factors, gradually 
influence the subject’s likelihood of suffering a stroke. It is the second leading cause of 
death1 and one of the commonest causes of disability in adults. In 2005 stroke 
accounted for 5.7 million deaths worldwide which is equivalent to 9.9% of all deaths. 
Two-thirds of those deaths will have occurred in people living in developing countries2. 
While India is still struggling with the problems of communicable diseases, 
noncommunicable diseases are on the rise. Stroke is potentially the most devastating 
consequence of vascular disease, causing serious long-term disability and incurring 
extremely high medical, emotional and financial costs. Hypertension is the number 
one risk factor for stroke. Control of hypertension can decrease the morbidity and 
mortality due to stroke. Age is an important and independent risk factor for stroke 
(Wolf et al 1992).3 20-30% of the hospital stroke population falls below the age of 40 
years (Nagaraja and Taly 1988).4 
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Objective 
 
The objective of the study was to evaluate the co –relation between the type of 
stroke, severity of stroke, risk factors leading to stroke, admission delay and stroke 
outcome. The stroke outcome was evaluated four weeks after onset using the NIH 
scale and Modified Rankin Scale.  
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Review of literature 
 
Stroke has been defined as a sudden neurological deficit characterized by loss of 
motor control, altered sensation, cognitive or language impairment and disequilibrium 
or coma caused by nontraumatic brain injury resulting from occlusion or rupture of 
cerebral blood vessels. 
Strokes are grossly categorized into ischemic and hemorrhagic. 85% of strokes are 
ischemic causing cerebral infarction. Of these ischemic strokes 40% are large vessel 
20% are small vessel and 20% are thromboembolic and 5% are vasculitis and other 
rare causes. 
Hemorrhagic strokes constitute the other 15%. They are further sub divided into 
intra cerebral hemorrhages (10%) and sub-arachnoid hemorrhages (5%).The etiology 
of the stroke can be inferred by classifying the temporal profile of the stroke from the 
patient’s history and clinical examination. TIA transient ischemic attack is an event 
when the neurological symptoms develop and disappear within 24 hours. RIND 
Reversible ischemic neurological deficit lasts longer than 24 hours. It is thought to be 
due to lacunar infarctions of the sub cortical gray and white matter. Embolic strokes 
occur within minutes while hemorrhagic strokes often evolve over 1-2 hours and 
ischemic strokes have a rapid or prolonged onset. 
Cerebral ischaemia causes not only reversible and then irreversible loss of  
 
brain function, but also cerebral oedema Ischaemic oedema it partly  
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'cytotoxic’ and partly 'vasogenic'. Cytotoxic oedema starts within minutes of  
 
stroke onset, and affects the grey more than the white matter, with damaged  
 
cell membranes allowing intracellular fluid to accumulate and apoptosis (Cell 
 
Death). 
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Risk factors 
Non –modifiable 
Age 
Gender 
Race 
Previous history of stroke 
Modifiable 
Hypertension 
Diabetes 
Atherosclerosis 
Atrial fibrillation 
Nicotine 
Sedentary lifestyle 
Oral contraceptives 
Metabolic syndrome 
Hypercoagulable states 
Hyperhomocysteinemia 
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Hypertension 
 
Hypertension is a definite predisposing factor for the development of a 
cerebrovascular accident. Hypertension causes endothelial injury, increases 
endothelial permeability to lipoprotein and the hemodynamic stress may precipitate 
plaque rupture. Macmohan et al found that 7.5mm of Hg reduction of diastolic blood 
pressure was associated with 46% reduction in stroke risk in hypertensive and 
subjects5 In the MRFIT (Multiple risk factor interventional trial) study6 increased 
mortality were associated with systolic BP more than 160mmHg and diastolic BP more 
than 95mmHg. The Systolic Hypertension in the Elderly program (SHEP)7 randomized 
4700 subjects over 60 yrs of age with systolic pressures of more than 160 mmHg and 
diastolic pressure more than  90 mm Hg to antihypertensive treatment and placebo. 
Over a period of five years subjects treated with anti-hypertensive medication had an 
average reduction of systolic blood pressure measuring 17 mmHg and 36% reduction 
in incidence of stroke compared to the control subjects. 
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Diabetes 
Bell8 has reviewed the literature describing the relationship between diabetes and 
stroke. Most ischemic strokes in diabetic patients are due to occlusion of small 
paramedial penetrating arteries. The occlusions cause small infarcts within the white 
matter of the brain. Diabetic autonomic neuropathy may contribute to the development 
of cerebrovascular disease in diabetics. The Diabetes Control and complication trial9 a 
prospective longitudinal study proved that intensive control of diabetic status reduced 
neurological complications by 60%. 
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Nicotine 
Smoking is an important independent risk factor confirmed by the Framingham study. 
The relative risk of stroke for heavy smoker is twice that of light smokers. Cessation of 
smoking reverses risk to that of non-smokers within 15 years of quitting. 
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Dyslipidemia 
The role of elevated cholesterol per se has not proved to increase stroke incidence, 
but along with development of atherosclerosis and coronary artery disease it has 
proven to be an indirect risk factor. There has been a strong relation between carotid 
artery atherosclerosis and increased serum cholesterol levels.10,11 
 
Clinical features 
1. Sudden numbness or weakness of the face, arm or leg especially on one side of 
the body. 
2. Sudden confusion, difficulty in talking or understanding speech 
3. Sudden difficulty in seeing in one or both eyes. 
4. Sudden difficulty in walking, dizziness or loss of balance or coordination. 
5. Sudden severe headache with no known cause. 
 
 INVESTIGATIONS: 
 
Once a stroke is suspected clinically a brain imaging study is necessary to determine 
if the etiology of stroke. Is it ischemic or hemorrhagic? Computed tomography [CT] 
imaging of the brain is the standard imaging modality to detect the presence or 
absence of intracranial hemorrhage. Early CT scanning of brain will not pick up the 
infarct but helps to exclude hemorrhage. Infarct may not be seen reliably for 24-48 
hours in CT brain. 
MRI reliably documents the extent and location of infarction in all areas of brain, 
including the posterior fossa and cortical surface. MRI is less sensitive than CT for 
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detecting acute bleed. Diffusion weighted imaging is more sensitive for early brain 
infarction than standard MR sequences, as is FLAIR [Fluid Attenuated Inversion 
Recovery] imaging. 
 
Other investigations to be done are 
Chest X ray 
ECG, 
Echocardiography. TEE 
Urine analysis, 
Complete blood count, 
Serum electrolytes, 
Blood urea nitrogen, 
Creatinine, 
Blood sugar, 
Serologic tests for AIDS, syphilis, 
Lipid profile 
Carotid Doppler 
M R Angiogram of neck vessels 
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Treatment 
The therapeutic goal of current stroke treatment is to stop neurological 
deterioration, limit neurological impairment and minimalize the functional disability. 
When the patient is medically stable rehabilitation is begun. 
Medical management 
Primary prevention  
The inexpensive aspirin is the first choice in a dose of 50-365mg/day12 
Secondary prevention 
Clopidogrel 75mg is the other anti-platelet agent used alone or in combination with 
aspirin. 
Statin therapy as per the SPARCIL trial13 atorvastatin upto 80mg recommended 
statins to prevent recurrent strokes 
Thrombolysis 
Surgical management 
 Carotid Endarterectomy, clot removal, surgical decompression 
Rehabilitaion  
Rehabilitation is started once the patient is neurologically stable. 
 Multi-disciplinary approach with Physiatrists, physical therapists, occupational 
therapists and speech therapists clinical psychologists,orthotist improve the stroke 
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outcome by 60%. Periodic assessment and care-giver counseling minimizes post-
stroke complications. 
Commonest complications are depression, respiratory infections, aspiration 
pneumonia, deep vein thrombosis, shoulder dysfunction, spasticity, falls and injuries, 
bladder and bowel dysfunction. These set-backs hamper stroke recovery and the 
patient and the family have loss of motivation – thus leading to an unfavourable stroke 
outcome. 
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Materials and Methods 
 
The format of the study was the WHO STEP wise stroke surveillance study and 
ICASS -2 study .This ICASS-II /WHO STEP wise stroke surveillance study is a sequel 
to the ICASS - I study conducted in 2002. ICASS is the acronym for Indian Co-
operative Acute Stroke Study done by the Indian Stroke Association. This is a 
prospective study conducted in 2 private hospitals under Prof .G. Arjundas (Prof. 
Emeritus TN MGR medical university). A total of 402 patients were evaluated at Vijaya 
Health Centre and Mercury Nursing Home in Chennai, India. WHO defines stroke as 
“a focal (or at times global) neurological impairment of sudden onset, and lasting more 
than 24 hours (or leading to death) and of presumed vascular origin”.14  The strokes 
were confirmed by CT scans or MRI magnetic resonance imaging. The study duration 
was from Dec 2003- Dec2004. A pilot study of 10 cases was evaluated before the 
actual study started in Dec.03. The WHO stroke surveillance part of the study focuses 
on hospitalized stroke patients only (STEP- 1).The data collection was by “hot pursuit”. 
Hot pursuit signifies active ongoing recruitment of stroke patients and not a 
retrospective (cold pursuit) collection of cases. We did not undertake the evaluation of 
strokes in the community (STEP -2 and STEP-3) due to our inability to conduct door to 
door surveys.  
The epidemiological data of age, gender, occupation, socio-economic status, race 
and religion were also obtained for the surveillance study. Inclusion criteria of stroke 
patients are the following. Those with sudden neurological deficit lasting 24 hours, 
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those with new neurological deficit in a different arterial territory within 28 days, those 
with new neurological deficit in the same arterial territory after 29 days were 
considered as a new stroke case. Those with new neurological deficit in the same 
arterial territory within 28 days were not considered as new stroke cases15. 
The type and sub-type of strokes were established and analyzed. The severity of 
strokes was evaluated by international scales such as the modified NIH(National 
Institute of Health) scale and the outcome by the Modified Rankin Scale (MRS).16 The 
NIH scale was evaluated on the day of admission and on the third day of admission. 
The highest NIH score was taken as the indicator of the severity of the stroke. The 
MRS was evaluated after 4 weeks by physical evaluation or by telephonic interview of 
the attendant.  In this study 4 week follow up was possible in 354 of the 402 patients. 
This was because some patients come from remote rural areas where communication 
links are inadequate and also due to illiteracy, the contact addresses were inadequate. 
The scoring of the Modified Rankin Scale is <3 where the patient is walking 
independently and requires no assistance for his/her activities of daily living (ADL). 
MRS score of 3-4 is where mobility assistance is required and 5 is where the patient is 
totally dependent for his ADL and MRS score of 6 is used to document the mortality.     
The risk factors of age, hypertension, diabetes mellitus, ischemic heart disease, 
dyslipidemia, anemia and nicotine intake were evaluated. 
Risk factor inclusion criteria are as follows. Hypertension is diagnosed if BP is 
>140/90 on 2 independent readings or on anti-hypertensive treatment. Diabetes 
mellitus is defined if 2 independent reading of blood glucose is >180mg/dl (post-
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prandial – venous sample) or an elevated glycosylated hemoglobin or on anti-diabetic 
treatment. Hyperlipidemia is defined if the total cholesterol was above 200mg/dl or 
LDL is more than 160mg/dl or triglycerides more than 150 mg/dl or VLDL is >26mg/dl. 
The statistical analysis used p-value and odds ratio using multiple logistic 
regression (forward stepwise addition method) to infer the statistical significance of the 
various risk factors. Pearson correlation analysis was also done to look for linear 
association between single and combination of risk factors. 
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Observations and results 
Age 
77.8% of our patients were between 50 and 79 years of age. The youngest patient 
was 17 years old and our oldest patient was 92 years. The morbidity with severe 
disability and death is greatest in the 6th to 8th decades as revealed by MRS Scores 
of 5 and 6. The p-value is 0.04 which is statistically significant. 
The mean age of stroke is 61.7. The standard deviation is 13.4.  
Table 1 Patients Age vs MRS Score 
Age  Modified Rankin Scale Score  p‐value 
<3  3‐4  5  6 
<29  5 2 0 2 0.04 (sig) 
 
χ2 = 34.09 
d.f. = 21 
 
30‐39  8 3 1 2
40‐49  17 2 1 1
50‐59  44 15 7 11
60‐69  55 31 26 12
70‐79  38 14 12 14
80‐89  12 4 4 8
90>  0 0 1 2
Total  179 71 52 52
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Gender 
 
We had 265 (65.9%) male patients and 137 (34.1%) female patients. The stroke 
outcome was evaluated in 354 patients and there was no statistical significance in 
relation to gender of the patient and stroke outcome. 
 
Table 2  Gender vs MRS Score 
Gender  Modified Rankin Scale Score  p‐value 
<3  3‐4  5  6 
Male  119  44  32  37  0..67 ( not sig) 
χ2 = 1.56 
d f = 3
Female  60  27  20  15 
Total  179  71  52  52 
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Admission delay 
 
 
 
 
 
 
 
 
 
Admission delay refers to the time window between the onset of symptoms of stroke 
and the onset of treatment. 49% of the patients reported to our hospital after 48 hours 
of onset of symptoms. The patients were taken to tertiary level centers after initial care 
in smaller nursing homes in neighboring towns and villages. Or there was a delay in 
identifying the stroke warning symptoms. Only 9% reached the hospital within 3 hours. 
 
9%
8%
6%
3%
11%
14%
49%
0-3hrs 3-6hrs 6-9hrs 9-12hrs
12-24hrs 24-48hrs >48hrs
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Severity of stroke 
The NIH (National Institute of Health) score is used to measure the severity of 
stroke. It was assessed on admission, the third day of illness and seventh day of 
illness. The score ranges from 0 – 42. The NIH score can be assessed within ten 
minutes and it has a high specificity. A score of NIH less than 5 (mild) had 64% 
independent stroke survivors. A score of 16 – 42 showed a morbidity of 38.5 percent 
and a mortality of 53.8%.  
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Type of stroke vs outcome 
In our study 77% of our strokes were ischemic and 17% were hemorrhagic strokes. 
Of these ischemic strokes 80% had a MRS less than 3 and 71% had MRS score of 6. 
However hemorrhagic strokes showed 30% and 25% MRS of 5 and 6. On statistical 
analysis there is a trend showing a likely increase in morbidity and mortality with 
hemorrhagic stroke. The p-value was 0.38 which is statistically insignificant. A larger 
case study would be required to confirm the statistical significance of the trend. 
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Size of infarct versus stroke outcome 
The TOAST classification (Trial of Org 10172 in Acute stroke treatment) of sub-
types of ischemic stroke was used. Large Artery atherosclerosis was when the infarct 
size was greater than 1.5cms in diameter on CT or MRI. Lacunar infarcts or small 
artery occlusion was when the infarct size was less than 1.5cms. Cardioembolic 
strokes, strokes of other determined etiology and undetermined etiology are the other 
three in this classification. As the majority of strokes belonged to large artery and 
small artery type we evaluated the stroke outcome in these categories. In the large 
artery type we had 66 patients with an MRS score of less than 3 and 72 patients with 
lacunar infarcts with a similar MRS score. The mortality was 29 in the former and 2 in 
the latter. On statistical analysis the p-value was <0.0001 which is statistically 
significant. 
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Modifiable Risk Factors 
Hypertension was found to be a major risk factor of stroke in 72 percent of the 
patients. It was found to be associated with stroke alone and in combination with 
diabetes mellitus and IHD. 49.8% had diabetes mellitus and 33.8% had ischemic heart 
disease. Around 16% of the patients in this study had no significant risk factor 
detected with the present facilities and methods available. 
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Table 3  Incidence of Modifiable Risk Factors 
Risk Factor  No of cases  Percentage 
Hypertension  289 71.9% 
Diabetes mellitus  200 49.8% 
Ischemic heart disease 136 33.8% 
Atrial fibrillation  13 3.2% 
Valvular heart disease  14 3.5% 
Congenital heart disease 2 0.5% 
Total Cholesterol  105 26.1% 
HDL Low  159 39.6% 
LDL  High  30 7.5% 
TGL  High  117 29.1% 
VLDL  High  155 38.6% 
Nicotine  95 23.6% 
Anemia  40 10.0% 
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Hypertension 
289 patients (72%) of the 402 were hypertensives. The 4 week follow up by 
modified Rankin scale was possible in 354 patients. Out of this 260 were diagnosed 
as stroke with hypertension as risk factor (HT alone or in combination with other risk 
factors). 140/90 mm Hg and above was taken as hypertensive. 129 of them had a 
MRS score of 0-2 (mild disability), 57 had a MRS score of 3-4 (moderate disability) 
and 41 had a MRS score of 5 (severe disability) and 33 patients died. The p – value is 
0.15 which is not statistically significant. Chi square = 5.31, d.f. =3. 
 
 
 
 
 
 
 
 
 
Risk factors
HT only
19%
HT & DM
26%
HT & IHD
12%
HT, DM & IHD
15%
DM & IHD
4%
IHD Only
2%
DM Only
6%
No Risk
16%
HT only HT & DM HT & IHD HT, DM & IHD DM & IHD IHD Only DM Only No Risk
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Diabetes 
200 (49.8%) patients were diabetic. Among these patients a 28 day follow up was 
possible in 173 patients. Blood sugar (post prandial venous sample) >180 mg/dl were 
taken as diabetes. 76 patients had an MRS score of 0-2 (mildly disabled) while 37 
patients had MRS score of 3-4 (moderate disability) and 27 patients had MRS score of 
5 (severe disability) and 33 expired. The p-value is 0.049, chi -square 7.87 and d.f = 3 
and is statistically significant.  
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Ischemic heart disease 
136 patients (33.8%) were found to have IHD. 126 of these patients were followed 
up at 28 days. These were diagnosed by the electrocardiogram and ECHO findings 
and confirmed by a cardiologist. 53 patients had MRS scores of 0-2 (mild disability) 
while 27 of them had MRS score of 3-4 (moderate disability) and 23 patients had MRS 
scores of 5 (severe morbidity). 23 patients expired. The p-value is 0.10 and chi square 
= 6.37. 
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Dyslipidemia 
The individual components of the lipid profile (such as total cholesterol, HDL, LDL, 
VLDL and TGL) were evaluated. Total cholesterol was evaluated in 271 patients of 
whom 176 had hypercholesterolemia and 95 had normal cholesterol values. 96 had a 
MRS score of <3 MRS of 3-4 and 24 had a score of 5 and 12 had a score of 6. P-
value = 0.21 which is statistically insignificant when compared with those who had 
normal values. 
LDL and stroke outcome was evaluated in 242 patients. 137 had an MRS score of 
<3 49 had a score of 3-4 and 27 had a score of 5 and 29 had a score of 6. The p-
value is 0.43 which is insignificant. 
The Triglyceride levels and stroke outcome were analyzed in 163 patients. 87 had 
MRS scores of <3. 33 had MRS score of 3-4 and 21 had a score of MRS 5 and 22 had 
a score of MRS 6. The p-value is 0.26 which is insignificant. 
The VLDL levels and stroke outcome were analyzed in 127 patients. 71 had a 
MRS score of<3, 23 had a MRS score of 3-4 and 19 had a MRS score of 5 and 14 
had a score of 6. The p-value is 0.42 which is not statistically significant. 
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Tobacco 
23.6 percent of the stroke patients consumed tobacco –either via smoking 
cigarettes or beedis, or chewing tobacco with betel leaves or nasal snuff. 10% of the 
patients were found to be anemic.   48 patients had a MRS score of <3 16 had a score 
of 3-4 and 8 had MRS scores of 5 and 8 had MRS scores of 6. The p-value is 0.42 
which is statistically insignificant. 
 
Table 4  Modifiable Risk Factors vs Stroke Outcome 
Risk factor  Modified Rankin Scale Score  p‐value 
<3 3‐4 5 6
Hypertension  129 57 41 33 0.15 
Diabetes mellitus  76 37 27 33 0.049 
IHD  53 27 23 23 0.37 
Total cholesterol  96 37 24 19 0.21 
LDL  137 49 27 29 0.43 
TGL  87 33 21 22 0.26 
VLDL  71 23 19 14 0.15 
Nicotine  48 16 8 8 0.42 
 
On evaluating a combination of risk factors diabetes and hypertension - the 
number of patients with 5 & 6 on the MRS showed severe morbidity and mortality than 
those with minimal disability <3.  
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Table 5 Modifiable risk factors ­ Alone and in Combination 
Risk factor 
Modified Rankin Scale Score 
total 
<3  3‐4  5  6 
Hypertension  42 14 10 4 70  
Diabetes mellitus  10 1 1 4 16 
Ischemic  4 2 0 2 8 
HT +DM  42 20 12 13 87 
HT+IHD  25 9 9 5 48 
DM+IHD  4 2 4 5 15 
HT + DM +  20 14 10 11 55 
No risk  32 9 6 8 55 
 
P=0.003 (significant) 
Chi‐square trend  8.81 
d.f =1 
 
There were only 8 stroke patients with IHD alone as the risk factor and only 15 
patients with Diabetes and Ischemic heart disease (out of 354) as the risk factors. This 
figure is too small to be statistically significant. However though there is an association 
of DM and IHD in the multi –factorial etiology of stroke these risk factors independently 
do not add any additional risk to the stroke outcome. 
When three or more risk factors are involved the mortality (MRS) rises to one-fifth. 
  Page 33 
 
Table 6 Regression Analysis Results 
Independent   Reg. 
coefficient
S.E (6)  p­value  Odds ratio  
Age  0.31  0.16  0.045  1.37 
Diabetes mellitus 0.71 0.31 0.02 2.02 
IHD  0.69  0.31  0.03  1.98 
 
The results of multiple logistic regression analysis shows, an increase in morbidity 
and mortality with the MRS scores more than 5 in the above risk factors of age, 
diabetes mellitus and ischemic heart disease. The non-significant variables are sex, 
hypertension and LDL (dyslipidemias). Hypertension is the most significant risk factor 
however the stroke outcome is not affected as there are proportionate numbers of 
hypertensives with favourable outcome too. However hypertension increased 
morbidity and mortality. 
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Discussion 
JD Pandian et al did a study on public awareness of stroke symptoms and risk 
factors and treatment at CMC Ludhiana, Punjab India in 2005.They found that of 942 
individuals stroke awareness was not there in 45% of subjects. 23% did not know a 
single symptom of stroke. 21% did not know a single risk factor of stroke. The results 
concur with the data of admission delay in our study where 49% reported for 
admission after 48 hours. The earlier the stroke warning symptoms and signs are 
recognized the lesser the neuronal damage and the better the stroke outcome17. 
According to Jeffrey L Saver , every minute in which a large vessel ischemic stroke is 
not treated, the average patient loses 1.9 million neurons, 13.8 billion synapses, and 
12 km (7 miles) of axonal fibers. Each hour, in which treatment is delayed, the brain 
loses as many neurons as it does in almost 3.6 years of normal aging. The newer 
treatments of tissue plasminogen activator (tPA) can reverse neurological deficit if the 
patient can reach a stroke unit within 3 hours of onset of symptoms. 
 
In our study the age group of maximum stroke incidence was 50-79 years with a 
mean age incidence of 61.7 +_ 13.4 (SD). In the German Stroke Data Bank study by 
Armin J Grau et al18 the age incidence was 65.9+_ 14.1. The above mentioned study 
also used the Modified Rankin scale to follow up the patients. Stephen Bagg19 from 
Ontario, Canada has reported that age in combination with severity of stroke has to be 
considered while predicting the impact on functional outcome. The outcome of stroke 
depending on the sub-type was similar to ours. A study done in Karachi Vohra EA20 
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also shows similar results of increased mortality and morbidity due to advancing age 
and cardiac illness. Majority of their cases were between 4th and 6th decade. They 
had 50% hypertensives, 19% CAD and 18% diabetes and 17% were smokers.  
 
Gender differences are present in the incidence of stroke in our study. 65.9% were 
men and 34.1% were women. However this could reflect the gender bias existing in 
Indian society. There is no statistically significant difference in the stroke outcome due 
to gender. 
 
A Malaysian study by Ong et al21 reported in 2002 concluded that hypertension and 
diabetes are the commonest risk factors of stroke admitted in a tertiary hospital in 
Malaysia. Their incidence of hypertension was 71.5% and diabetes was 40.2% which 
was similar to ours. They had a mortality rate at one month of 20.3% while we had a 
mortality rate of 14%.  In this study they used the Glasgow Coma Scale to assess the 
severity of stroke. We found the NIH scale more specific. 
 
In our study elevated total cholesterol, LDL, VLDL, TGL and lower HDL values 
have not directly contributed to the incidence of ischemic or hemorrhagic stroke. 
Similar finding have been observed by Ross et al.22  Ross R found that elevated 
serum cholesterol has not been linked to an increased stroke incidence. However it 
indirectly increases stroke risk due to hypercholesterolemia and coronary artery 
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disease. Two large meta-analyses 23 , 24 aggregated from very large cohorts failed to 
find a relationship between cholesterol and stroke. However the MRFIT study25  in 
350,977 men aged 35-57 years found that a clear relationship emerged when stroke 
was categorized into ischemic and hemorrhagic types. The risk of ischemic stroke 
rose with increased cholesterol, and hemorrhagic stroke rising with lowest cholesterol 
values. 
 
Another large 10-year prospective study in Britain by Wannamethee SG (Stroke 
2000),26 of 14,175 middle-aged men and women, free of clinical cardiovascular 
disease at the outset, found a weak inconsistent relationship between low density 
lipoprotein-cholesterol (LDL-c) or high density lipoprotein-cholesterol (HDL-c) and 
ischemic stroke. In the WHO 2004 study by Ezzah M, Lopez AD et al found a definite 
global and regional burden due to raised total cholesterol level leading to 4.4 million 
deaths annually. 
 
Samy I.Mcfarlane27 et al have concluded that the lowering of blood pressure to 
<130/80 mm of Hg is strongly recommended for the primary and secondary prevention 
of stroke. Lowering LDL<100mg/dl in diabetics without prior stroke and <70mg/dl in 
diabetics with stroke is currently recommended.  
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23.6% of our patients used nicotine in the form of chewing tobacco, nasal snuff, 
cigarettes and beedis. Our figures show increased mortality and morbidity in nicotine 
consumers compared to those who do not. (p= 0.009 statistically significant) Smokers 
both current and past have a higher risk of developing stroke was earlier quoted by 
Ruth Bonita et al 1986.28  
 
Lefkovits J, of Royal Melbourne Hospital Australia,29 found that age, cardiac 
disease and diabetes all independently worsen acute stroke outcome – this is similar 
to our Indian findings. 
 
The Framingham Heart study identified hypertension, diabetes mellitus, 
hyperlipidemia and smoking as the major atherogenic factors for stroke30. In rural 
Japan a low serum cholesterol was associated with increased risk of cerebral 
hemorrhage31.An Indian study by Dalal et al in Mumbai showed significant association 
of heart disease, hypertension and smoking and stroke32. The findings were similar to 
the data analyzed in our study. 
 
Katedry i Kliniki Neurologii AM w Lublinie Szczepanska-Szerej A et al33 found in a 
Polish study in 2003 that diabetes has no effect on the course and outcome of 
ischemic stroke. In contrast we found that in our Indian subcontinent Diabetes is an 
independent risk actor by itself in increasing the morbidity. A Spanish study by Arboix 
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et al34 of 393 diabetics with stroke found that they had a different clinical pattern of 
ischemic stroke with atherothrombotic stroke and lacunar infarcts being more frequent. 
It also affected the in-hospital mortality. 
 
In our study 16% of our stroke patients had no known risk factors (cryptogenic). 
Catalina & Adnan Qureshi et al35 have found upto 30% of strokes can remain 
cryptogenic after excluding the identifiable risk factors including septal defects.  
Unidentified environmental and genetic factors may play a role. 
Appelros et al36 studied stroke outcome after one year, while we studied outcome 
at one month. He found that along with age and stroke severity, dementia also played 
an important role in morbidity, recurrence of stroke and mortality. 
 
Johnston et al37 found a multivariable relationship between clinical variables and 
imaging as predictors of stroke outcome at 3 months. 
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Conclusion 
 
Prediction of the outcome of stroke essentially depends on the age, admission 
delay, sub-type of ischemic stroke and the severity of stroke. The NIH score on the 
third day and seventh day of illness proved to be an essential tool in evaluating the 
severity of the stroke. The morbidity and mortality of stroke as determined by the 
outcome at 4 weeks by the modified Rankin scale, is significant in patients with a 
combination of risk factors such as diabetes and ischemic heart disease and nicotine. 
The gender of the individual did not alter the outcome. Though hypertension increased 
the incidence of stroke, hypertension and dyslipidemia did not alter the stroke 
outcome directly in this study. Prediction of stroke outcome enabled the patient, the 
care-giver and the family to prepare for mild, moderate or severe disability.  
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Annexures 
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NIH Stroke Scale 
 
Ref: Goldstein LB, Samsa GP; Stroke 1997;28:307-10 
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TOAST Classification 
 
 
Â Trial of Org 10172 in Acute Stroke Treatment 
Â Large Artery atherosclerosis  
Â >1.5 cm 
Â Cardio‐embolism 
Â Small vessel occlusion 
Â <1.5 cm 
Â Stroke of other determined etiology 
Â Stroke of other undetermined etiology 
Â Reference – Stroke 1993 Jan;24(1):35‐41 
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Modified Rankin Scale 
 
0 No symptom at all 
1 No significant disability despite symptoms, able to 
carry out all usual activities 
2 Slight disability, Unable to carry out all previous 
activities but able to look after own affairs without 
assistance 
3 Moderate disability, requires some help but able to walk 
without assistance 
4 Moderately severe disability, unable to walk without 
assistance and unable to attend ADL without assistance 
5 Severe disability, bedridden, incontinent and requiring 
constant nursing care and attention 
6 Death 
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SAMPLE CASE SHEET 
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